Stay updated on Oraxol vs Taxol in Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Oraxol vs Taxol in Breast Cancer Clinical Trial page.

Latest updates to the Oraxol vs Taxol in Breast Cancer Clinical Trial page
- ChecktodayChange DetectedRevision from v3.3.3 to v3.3.4 is shown; no substantive changes to the study details, eligibility criteria, or endpoints are evident in the record.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedAdded location entries for Buenos Aires, Córdoba Province, La Pampa Province, and Río Negro Province, and removed the corresponding location subsections; revision: v3.3.3.SummaryDifference0.4%

- Check51 days agoChange DetectedA note was added that PubMed publications shown are automatically filled and may not all be about the study. The revision tag was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check58 days agoChange DetectedRemoved the government funding status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check79 days agoChange DetectedNo significant changes detected on the Study Details page between the two screenshots. The core content, including the study title, conditions, eligibility, and outcomes, remains the same.SummaryDifference0.3%

- Check101 days agoChange DetectedUpdated version to v3.2.0 and added a government operating-status notice for NIH Clinical Center, directing users to cc.nih.gov and opm.gov.SummaryDifference3%

Stay in the know with updates to Oraxol vs Taxol in Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oraxol vs Taxol in Breast Cancer Clinical Trial page.